An international team of researchers found that a cholesterol-lowering drug may offer a more effective and convenient way to ...

A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to ...

A discussion about screening for Lp(a), a factor that can contribute to hypertension, with Wenjun Fan, MD, PhD, and Arya Aminorroaya, MD, MPH.

Health experts have expressed serious concerns over the growing prevalence of high cholesterol levels among the population, warning that this could trigger an alarming increase in heart-related ...

High levels of bad cholesterol (LDL) can clog arteries, increase the risk of heart disease and stroke, and often result from ...

A new fixed-dose combination therapy pairing obicetrapib with the cholesterol-lowering drug ezetimibe significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients whose ...

Cholesterol tests check the components of fat in your blood and compare them to normal ranges. Your clinician might also use ...

The Family Heart Foundation, a leading research and advocacy organization focused on the role of lipids in cardiovascular ...

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or ...

Recent evidence has suggested that the use of norrin mimetics targeting both frizzled-4 (FZD4) and low-density lipoprotein receptor-related protein 5 (LRP5) may be highly effective at modulating ...

The main message is that absolute levels of Lp(a) matter more than which genes may have caused them, Robert Clarke says.